Search
Search Constraints
You searched for: Is Part Of Cytokine. Volume 89(2017)Limit your search
- 571.844 31
- Cytokines -- Periodicals 31
- ALP Alkaline phosphatase -- BFR bone formation rate -- BSP Bone sialoprotein -- BV/TV bone volume/total volume, trabecular bone fraction -- CTX carboxy-terminal collagen crosslinks -- Conn.D connectivity density -- rHuEPO Erythropoietin (EPO)/recombinant human EPO -- EPO-R Erythropoietin receptor -- FBS fetal bovine serum -- M-CSF macrophage colony stimulating factor -- M-CSF-R CSF1-R, cFms, macrophage colony stimulating factor receptor -- MSCs mesenchymal stem cells -- Tg6 mice over-expressing human EPO gene -- μCT microcomputed tomography -- MAR mineral apposition rate -- MS/BS mineralizing surface/bone surface -- OCN Osteocalcin -- N.Oc/BS osteoclast number/bone surface -- OPG osteoprotegerin -- RANK receptor activator of nuclear factor kappa B -- RANKL receptor activator of nuclear factor kappa B ligand -- TRAP tartrate-resistant acid phosphatase -- Tb.N trabecular number -- WT wild type 1
- Adiponectin -- Chronic hepatitis C -- Biomarker 1
- BAD Bcl2-associated agonist of cell death -- Bcl B-cell lymphoma -- CD cluster of differentiation -- CDK cyclin-dependent kinase -- CTL cytotoxic T lymphocyte -- CUG cancer upregulated gene -- CXCL C-X-C motive ligand -- DC dendritic cells -- DAMP danger-associated molecular pattern -- DR death receptor -- ER estrogen receptor -- ERBB2/neu Erb-B2 receptor tyrosine Kinase 2 -- ERK extracellular signal-regulated kinase -- FASL FAS ligand -- FADD Fas-associated protein with death domain -- FGF fibroblast growth factor -- HDAC histone deacetylase -- HIF hypoxia-inducible factor -- IFN interferon -- IFNAR IFNα/β receptor -- IFNGR IFNγ receptor -- IL interleukin -- IRDS IFN-related DNA damage resistance signature -- IRES internal ribosome entry site -- IRF interferon regulatory factor -- ISG interferon-stimulated gene -- JAK Janus kinase -- JNK c-Jun N-terminal kinase -- MCA methylcholanthrene -- MDM2 mouse double minute 2 homolog -- MDR multidrug resistance -- MDSC myeloid-derived suppressor cell -- MEF mouse embryonic fibroblast -- MHC class I major histocompatibility complex class I -- miRNA microRNA -- MMP matrix metalloproteinase -- MUC mucin -- NFκB nuclear factor kappa B -- NK natural killer -- PDCD programmed cell death -- PD-L1 programmed death-ligand 1 -- PIAS protein inhibitors of activated STATs -- PRR pattern recognition receptor -- pSTAT tyrosine phosphorylated STAT -- Rb retinoblastoma -- RIG-1 retinoic acid inducible gene 1 -- RIP receptor interacting protein kinase -- SHP2 SH2 domain-containing protein-tyrosine phosphatase -- SOCS suppressor of cytokine signalling -- STAT signal transducer and activator of transcription -- S727 serine 727 -- TAM tumour-associated macrophage -- TGF transforming growth factor -- TLR toll-like receptor -- TNBC triple negative breast cancer -- TNF tumour necrosis factor -- TRADD TNFR1-associated death domain protein -- TRAF TNF-receptor associated factor -- TRAIL TNF-related apoptosis-inducing ligand -- U-STAT unphosphorylated STAT -- VEGF vascular endothelial growth factor -- XIAP X-linked inhibitor of apoptosis protein -- Y701 tyrosine 701 1
- BC breast cancer -- CC cervical cancer -- CMV cytomegalovirus -- CRC colorectal cancer -- HCC hepatocellular cancer -- Hly hemolysin, an exotoxin produced by bacteria. -- HSC hematopoietic stem cells -- LC lung cancer -- LPS lipopolysaccharide -- PC prostate cancer -- PSA prostate-specific antigen -- RCC renal cell cancer -- SCC squamous cell cancer -- SPI Salmonella pathogenicity islands -- DLT dose-limiting toxicity – a single minimal dose of a therapeutic agent that results in unacceptable side effects or toxicity in a cohort -- MTD maximum tolerated dose – a single maximal dose of a therapeutic agent that produces the desired response(s) with acceptable side effects or toxicity in a general population. This value is less than DLT -- Exotoxins a family of bacterial proteins secreted or injected using type-I/II secretory apparatus targeting specific host components. Toxins that target host cytosolic proteins include Cholera, Diphtheria, Pertussis and Shiga toxins while another group that creates pores on host cell membrane includes cholesterol-dependent cytolysins and RTX toxins -- Epitope spread a phenomenon where multiple antigen-specific immune responses are triggered that are unrelated, in sequence or structure, to the primary immunogen 1
- Breast cancer -- Interleukin-35 -- Invasive ductal carcinoma -- Tumor-infiltrating lymphocytes 1
- CXCL13 -- IL-31 -- Hepatocellular carcinoma -- ROC curve 1
- Cancer -- Bio-therapy -- Bacterial vectors -- Tumor suppression -- Immune response 1
- Cancer-cachexia -- White adipose tissue -- Interferon-γ signalling 1